Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

Courtney D. DiNardo, Brian A. Jonas, Vinod Pullarkat, +27

New England Journal of Medicine

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

Vassily Trubetskoy, Antonio F. Pardiñas, Ting Qi, +360

Nature

PsychiatryGeneticsPsychiatric GeneticsSchizophreniaNeuroscience +5

Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Yoon‐Koo Kang, Narikazu Boku, Taroh Satoh, +20

The Lancet

Esophageal CancerGastrointestinal OncologyLeast TwoMedicineGastroenterology +6

Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study

Chi Pang Wen, Jackson Pui Man Wai, Min Kuang Tsai, +7

The Lancet

Physical ActivityKinesiologyAdapted Physical ActivityHealth PolicyPhysical Activity Epidemiology +6

A marker for Stevens–Johnson syndrome

Wen‐Hung Chung, Hong‐Shang Hong, Mo‐Song Hsih, +4

Nature

ImmunodeficienciesHistopathologyExperimental PathologyPathologyGeneral Pathology +5

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

Wen‐Hung Chung, Lieh-Bang Liou, C.C. Chu, +15

Proceedings of the National Academy of Sciences

A survey on security and privacy of federated learning

Viraaji Mothukuri, Reza M. Parizi, Seyedamin Pouriyeh, +3

Future Generation Computer Systems

EngineeringData ScienceInformation SecurityFederated LearningFederated Structure +7

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

Ken Kato, Byoung Chul Cho, Masanobu Takahashi, +15

The Lancet Oncology

Esophageal CancerGastrointestinal OncologyMedicinePrevious ChemotherapyNivolumab Versus Chemotherapy +5

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky, +78

The Lancet

NanomedicineOncologyPancreatic CancerMedicineFolinic Acid +6

Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth

Lin Zhang, Siyuan Zhang, Jun Yao, +19

Nature

Developmental BiologyAutophagyBiological MicroenvironmentsCellular SenescenceSmall Rna +7